Cheima Bouziane - Publications

Affiliations: 
Academic Medical Center Amsterdam, Amsterdam, Netherlands 

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Tamminga HGH, Reneman L, Schrantee A, Bottelier MA, Bouziane C, Geurts HM, Groenman AP. Do effects of methylphenidate on cognitive performance last beyond treatment? A randomized placebo-controlled trial in boys and men with ADHD. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 46: 1-13. PMID 33735707 DOI: 10.1016/j.euroneuro.2021.02.002  0.754
2020 Solleveld MM, Schrantee A, Baek HK, Bottelier MA, Tamminga HGH, Bouziane C, Stoffelsen R, Lucassen PJ, Van Someren EJW, Rijsman RM, Reneman L. Effects of 16 Weeks of Methylphenidate Treatment on Actigraph-Assessed Sleep Measures in Medication-Naive Children With ADHD. Frontiers in Psychiatry. 11: 82. PMID 32184743 DOI: 10.3389/Fpsyt.2020.00082  0.718
2019 Bouziane C, Filatova OG, Schrantee A, Caan MWA, Vos FM, Reneman L. White Matter by Diffusion MRI Following Methylphenidate Treatment: A Randomized Control Trial in Males with Attention-Deficit/Hyperactivity Disorder. Radiology. 182528. PMID 31407970 DOI: 10.1148/Radiol.2019182528  0.792
2018 Bouziane C, Caan MWA, Tamminga HGH, Schrantee A, Bottelier MA, de Ruiter MB, Kooij SJJ, Reneman L. ADHD and maturation of brain white matter: A DTI study in medication naive children and adults. Neuroimage. Clinical. 17: 53-59. PMID 29527472 DOI: 10.1016/J.Nicl.2017.09.026  0.778
2017 Bottelier MA, Schrantee A, Ferguson B, Tamminga HGH, Bouziane C, Kooij JJS, de Ruiter MB, Reneman L. Age-dependent effects of acute methylphenidate on amygdala reactivity in stimulant treatment-naive patients with Attention Deficit/Hyperactivity Disorder. Psychiatry Research. 269: 36-42. PMID 28938219 DOI: 10.1016/J.Pscychresns.2017.09.009  0.771
2017 Schrantee A, Bouziane C, Bron EE, Klein S, Bottelier MA, Kooij JJ, Rombouts SA, Reneman L. Long-term effects of stimulant exposure on cerebral blood flow response to methylphenidate and behavior in attention-deficit hyperactivity disorder. Brain Imaging and Behavior. PMID 28321605 DOI: 10.1007/S11682-017-9707-X  0.77
2017 Schrantee A, Mutsaerts H, Bouziane C, Tamminga H, Bottelier MA, Reneman L. The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit/hyperactivity disorder. Neuroimage. Clinical. 13: 123-129. PMID 27942455 DOI: 10.1016/J.Nicl.2016.11.021  0.771
2016 Schrantee A, Tamminga HG, Bouziane C, Bottelier MA, Bron EE, Mutsaerts HM, Zwinderman AH, Groote IR, Rombouts SA, Lindauer RJ, Klein S, Niessen WJ, Opmeer BC, Boer F, Lucassen PJ, et al. Age-Dependent Effects of Methylphenidate on the Human Dopaminergic System in Young vs Adult Patients With Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. Jama Psychiatry. PMID 27487479 DOI: 10.1001/Jamapsychiatry.2016.1572  0.777
2015 Schrantee A, Mutsaerts H, Tamminga G, Bouziane C, Bottelier M, Rombouts S, Reneman L. P.1.i.044 The effects of methylphenidate on striatal dopamine system are dependent on age: a pharmacological magnetic resonance imaging study European Neuropsychopharmacology. 25: S326-S327. DOI: 10.1016/S0924-977X(15)30403-X  0.675
2015 Solleveld M, Schrantee A, Bouziane C, Ruhé H, Reneman L. P.1.i.043 Age-dependent effects of selective serotonin reuptake inhibitor exposure on the development of the GABA-ergic system European Neuropsychopharmacology. 25: S325-S326. DOI: 10.1016/S0924-977X(15)30402-8  0.656
2014 Bottelier MA, Schouw ML, Klomp A, Tamminga HG, Schrantee AG, Bouziane C, de Ruiter MB, Boer F, Ruhé HG, Denys D, Rijsman R, Lindauer RJ, Reitsma HB, Geurts HM, Reneman L. The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design. Bmc Psychiatry. 14: 48. PMID 24552282 DOI: 10.1186/1471-244X-14-48  0.611
Show low-probability matches.